As a target of miR-132 and miR-27a, Smad9 was also highlighted as a strong indicator of AD onset in our prior studies that had examined the molecular pathogenesis of cerebral vessels of aging 3xTg-AD animals (Chum et al., 2022, 2024). The gene discussed is SMAD9; the disease is Alzheimer disease.